Treatment advances in multiple myeloma
Open Access
- 17 February 2004
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 125 (1) , 24-30
- https://doi.org/10.1111/j.1365-2141.2004.04851.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patientsBlood, 2001
- Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell LinesBlood, 1999
- Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic CellsJournal of Clinical Oncology, 1999
- Total Therapy With Tandem Transplants for Newly Diagnosed Multiple MyelomaBlood, 1999
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Plasma Cell DyscrasiasPublished by American Medical Association (AMA) ,1992
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990